The erythroid/myeloid lineage fate paradigm takes a new player

2Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The erythroid versus myeloid lineage fate decision controlled by cross-antagonism between GATA1 and PU.1 serves as a mechanistic paradigm for transcription factor interplay during lineage specification. In this issue of The EMBO Journal, Monteiro et al (2011) examined this paradigm in blood populations in zebrafish embryos, and demonstrated that, unexpectedly, the regulatory interactions between GATA1 and PU.1 lead to different outcomes depending on the cellular contexts and the development stages. GATA1/PU.1 cross-antagonism is also modulated by a third factor transcriptional intermediate factor 1γ (TIF1γ), a chromatin-associated haematopoietic regulator. © 2011 European Molecular Biology Organization | All Rights Reserved.

Cite

CITATION STYLE

APA

Xu, J., & Orkin, S. H. (2011). The erythroid/myeloid lineage fate paradigm takes a new player. EMBO Journal, 30(6), 983–985. https://doi.org/10.1038/emboj.2011.45

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free